Characterizing Burnout in Health Professionals: Insights from the BEATS Study in Portugal

By João L. Carapinha

January 27, 2026

burnout health professionals

Burnout Health Professionals: Join the BEATS Study Call

Burnout health professionals in Portugal are invited to participate in the BEATS study, an initiative by the Portuguese Laboratory for Healthy Work Environments. Titled “BEATS – Burnout, Expectativas e Ambientes de Aprendizagem e Trabalhos Saudáveis” (Burnout, Expectations, and Healthy Learning and Work Environments), it characterizes burnout health professionals and examines workplace ecosystems as protective or risk factors. Collaboration with the Ordem dos Farmacêuticos urges pharmacists’ involvement for representativeness, using an anonymous 15-minute questionnaire for academic purposes.

Workplace ecosystems profoundly influence burnout health professionals experience, acting as safeguards or amplifiers. The BEATS study explores these dynamics in Portuguese health settings, analyzing environmental factors. It targets active practitioners, spotlighting pharmacists to capture profession-specific trends. This ecosystem lens promotes tailored interventions, blending organizational and worker contexts beyond individual evaluations.

The BEATS study’s questionnaire can be completed in 15 minutes by health professionals in Portugal. It stresses sincere responses with no right or wrong answers, upholding anonymity and confidentiality for research only. Participants can opt in or out freely. Led by Prof.ª Doutora Tânia Gaspar from SPIC/Universidade Lusófona, it meets ethical norms, offers clarification contacts, and falls under National Data Protection Authority oversight—ensuring robust burnout data without privacy risks.

BEATS will likely lead to occupational health costs in Portugal. By pinpointing modifiable ecosystems, it guides retention-boosting interventions, curbing absenteeism and turnover in roles like pharmacy. Results could back modeling of policy interventions towards healthy environments, offsetting healthcare spends and aligning with preventive trends for sustainable healthcare delivery.

Reference url

Recent Posts

regulatory validation taletrectinib
Advancing Regulatory Validation Taletrectinib for Enhanced NSCLC Treatment

By João L. Carapinha

June 30, 2026

The MHRA’s validation of Nuvation Bio’s marketing authorisation application marks an important regulatory validation taletrectinib for adults with advanced ROS1-positive non-small cell lung cancer. This milestone, achieved via the International Recognition Procedure in parallel with EMA review, f...
Portuguese Biotech Innovation
Global Impact of Portuguese Biotech Innovation

By João L. Carapinha

June 30, 2026

Portuguese Biotech Innovation has matured into a compelling global force, with Solfarcos marking a decade of translating University of Minho research into commercial technologies that span cosmetics and pharmaceuticals. The Braga-based spin-off has built a unified platform of peptides and protein...
cannabis regulatory exploitation
Exposing Cannabis Regulatory Exploitation in Portugal’s Medicinal Sector

By João L. Carapinha

June 30, 2026

Portugal’s medicines regulator INFARMED has been shaken by a major case of cannabis regulatory exploitation in which criminal networks weaponised medicinal cannabis licences to traffic drugs on an industrial scale. Insufficient inspectors, rapid sector growth and the recruitment of former agency ...